Poster: Methodology - New Modelling Approaches

Model Based Network Meta-Analysis for Pharmacometrics and Drug-Development: a 3 year Research Collaboration between Pfizer and the University of Bristol.

Thursday 16 October, 2025

Objectives: Meta-analysis is a well-established methodology for combining the results of randomised controlled trials (RCTs) that compare the same treatments…

Read more

Finding underlying longitudinal patterns in pharmaco-metabolomics data

Thursday 16 October, 2025

Objectives: To develop a method that integrates multidimensional pharmaco-metabolomics data into a single PKPD systems pharmacology model in a data-driven manner,…

Read more

Population PK/PD modeling of granocyte colony-stimulating factors given as single and repeated doses in healthy volunteers.

Thursday 16 October, 2025

Objectives: To develop a PK/PD population model to describe and compare the experimental observed profiles of two different formulations of lenograstim,…

Read more

Investigation of Bayesian inference in predicting tissue concentrations using RStan

Thursday 16 October, 2025

Background & Objectives: A full PBPK model representing physiological profiles may not be available due to limited data. Minimal PBPK…

Read more

Methods and tools for multiscale modelling in Systems Pharmacology: a review

Thursday 16 October, 2025

Objectives: Systems Pharmacology aims to quantitatively study the dynamic interactions between drugs and biological systems by integrating models and data…

Read more

Predictive assessments of pharmacokinetic alterations in subjects with renal disease

Thursday 16 October, 2025

Objectives: To find a model capable of predicting, relying on a minimum amount of PK information in normal subjects, the effect…

Read more

Dose-response-time modelling – Second generation turnover model with integral feedback control

Thursday 16 October, 2025

Objectives: To demonstrate the utility of a dose-response-time (DRT) model using a large preclinical biomarker dataset of nicotinic acid (NiAc) induced…

Read more

Comparison of the power and type-1 error of composite score models for drug effect detection in clinical trials

Thursday 16 October, 2025

Objectives: Many clinical trial endpoints are measured with composite scales which provide a measure of disease severity. A composite scale…

Read more

Modeling & Simulation of Long-Term Body Weight Loss during Obesity Pharmacotherapy

Thursday 16 October, 2025

Objectives: Obesity pharmacotherapy can lead to clinically meaningful long-term body weight loss [1]. In early Proof-of-Concept studies, drug effects on…

Read more

Focusing on the essential dynamics of systems pharmacology models by exploiting an input-response characterisation

Thursday 16 October, 2025

Objectives:  A growing understanding of complex biological processes has led to large-scale mechanistic, nonlinear models of pharmacologically relevant processes. These…

Read more